Hyperfine, Inc.

the swoop® system brings mr brain imaging within reach. our mission is to revolutionize patient care globally through transformational, accessible, clinically relevant diagnostic imaging and data solutions. hyperfine, inc. (nasdaq: hypr) is the groundbreaking medical technology company that has redefined brain imaging with the swoop® system—the world’s first fda-cleared, portable, ultra-low-field, magnetic resonance brain imaging system capable of providing imaging at multiple points of care. the swoop® system received initial u.s. food and drug administration (fda) clearance in 2020. it is a portable ultra-low field magnetic resonance imaging device for producing images that display the internal structure of the head where full diagnostic examination is not clinically practical. when interpreted by a trained physician, these images provide information that can be useful in determining a diagnosis.